EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF

Wancong Zhang, Liyun Chen, Jing Zhao, Aiwei Ma, Wenqi Shi, Yiwen Zhang, Zixuan Tang, Jiarui Guo, Zaihua Xu, Jianda Zhou, Shijie Tang iD

Advanced Science · 2025

DOI: 10.1002/advs.202503106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Wancong Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery and Burn Center, Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515051, China. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Ubiquitin-Specific Proteases, Tumor Suppressor Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma, a highly malignant skin cancer, has seen a rising incidence and death toll. MRGPRF is a novel melanoma suppressor that inhibits the PI3K/AKT pathway. However, the regulation of MRGPRF in melanoma remains unclear. Here, 40 ubiquitin‐specific proteases (USPs) are screened and USP45 is identified as a significant stabilizer of MRGPRF. Immunohistochemistry on melanoma patient biopsies demonstrates that USP45 expression is markedly reduced in melanoma tissues compared to adjacent noncancerous epidermis. Bioinformatic analyses corroborate that USP45 mRNA levels are downregulated in melanoma, and low USP45 expression is associated with poor patient prognosis. Functional assays demonstrate that USP45 overexpression inhibits melanoma cell malignancy, whereas USP45 knockdown promotes it. Mechanistically, USP45's catalytic domain directly binds to the N‐terminal of MRGPRF and stabilizes MRGPRF, likely by removing its K63‐linked ubiquitination in melanoma cells. The antimelanoma effects of USP45 are mitigated by MRGPRF depletion, while MRGPRF overexpression rescues the enhanced malignant phenotype induced by USP45 deficiency. In vivo, a melanoma xenograft mouse model shows that USP45 overexpression significantly impairs melanoma progression. These findings establish USP45 as a melanoma suppressor, at least partially through its stabilization of MRGPRF, highlighting a novel mechanism in melanoma pathogenesis and suggesting that USP45 agonists may serve as potential therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsUbiquitin-Specific ProteasesTumor Suppressor ProteinsReceptors, G-Protein-CoupledHumansCell Line, TumorXenograft Model Antitumor AssaysFemaleAnimalsMiceMice, NudeGene Expression Regulation, NeoplasticProtein StabilityEpidermisUbiquitinationGene Knockdown TechniquesKaplan-Meier EstimatePrognosisDisease ProgressionCarcinogenesisProteostasis

Stichwörter der Autor:innen

MRGPRFUSP45melanomaubiquitination

Substanzen

USP45 protein, humanUbiquitin-Specific ProteasesTumor Suppressor ProteinsReceptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Plastic Surgery and Burn Center, Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, 515051, China.
  • Plastic Surgery Institute of Shantou University Medical College, Shantou, Guangdong, 515051, China.
  • Shantou Plastic Surgery Clinical Research Center, Shantou, Guangdong, 515051, China.
  • Research Center of Translational Medicine, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515051, China.
  • College of Medicine, Shantou University, Shantou, Guangdong, 515051, China.
  • Department of Plastic and Reconstructive Surgery, Central South University Third Xiangya Hospital, Changsha, Hunan, 410000, China.

ORCID-Profile: Shijie Tang

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • 2020 Li Ka Shing Foundation Cross-Disciplinary Research Grant
  • Guangdong University Innovation Team Project
  • Provincial science and technology innovation strategy special project funding program
  • 2022 Shantou University Graduated Student Innovation Program
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Zhang, W., Chen, L., Zhao, J., Ma, A., Shi, W., Zhang, Y., Tang, Z., Guo, J., Xu, Z., Zhou, J., & Tang, S. (2025). USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF. Advanced Science. https://doi.org/10.1002/advs.202503106

Vancouver

Zhang W, Chen L, Zhao J, Ma A, Shi W, Zhang Y, et al. USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF. Advanced Science. 2025. doi:10.1002/advs.202503106

BibTeX
@article{Zhang2025,
  author = {Zhang, Wancong and Chen, Liyun and Zhao, Jing and Ma, Aiwei and Shi, Wenqi and Zhang, Yiwen and Tang, Zixuan and Guo, Jiarui and Xu, Zaihua and Zhou, Jianda and Tang, Shijie},
  title = {USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202503106}
}
Kostenlos starten →